Srikumar P. Chellappan
Affiliations: | Biology (Cell Biology, Microbiology, Molecular Biology) | University of South Florida, Tampa, FL, United States |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"Srikumar Chellappan"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bora-Singhal N, Saha B, Mohankumar D, et al. (2022) A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis. Cancer Research Communications. 2: 624-638 |
| Sriramareddy SN, Faião-Flores F, Emmons MF, et al. (2022) HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer Gene Therapy |
| Padmanabhan J, Saha B, Powell C, et al. (2021) Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells. Cancers. 13 |
| Rivera-Rivera Y, Marina M, Jusino S, et al. (2021) The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells. Scientific Reports. 11: 9016 |
| Maan M, Agrawal NJ, Padmanabhan J, et al. (2020) Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells. Biochimica Et Biophysica Acta. Molecular Cell Research. 118929 |
| Bora-Singhal N, Mohankumar D, Saha B, et al. (2020) Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2. Scientific Reports. 10: 4722 |
| Jusino S, Chellappan SP, Saavedra HI. (2020) Role of E2F3 and shugoshin I in epithelial-to-mesenchymal transition and cell invasion in breast cancer. Journal of Clinical Oncology. 38: e13100-e13100 |
| Maan M, Dutta M, Jaiswal N, et al. (2020) Abstract 1523: Novel role of TBK1 in breast cancer EMT Tumor Biology |
| Khambati F, Padmanabhan J, Chellappan S. (2020) Abstract 1011: Tank binding kinase (TBK1) inhibitor BX795 impairs anti-tumor efficacy of T cells by abrogating granzyme and perforin mobilization Immunology. 80: 1011-1011 |
| Sikder S, Kumari S, Kumar M, et al. (2019) Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. Oncotarget. 10: 6855-6869 |